Capital International Investors’s BioNTech BNTX Stock Holding History

Capital International Investors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,134,941	Closed	-$108M	–	440
2025 Q4	$108M	Sell	1,134,941 -125	-0%	-$12.6K	0.02%	287
2025 Q3	$112M	Buy	1,135,066 +1,593	+0.1%	+$170K	0.02%	286
2025 Q2	$121M	Sell	1,133,473 -294,968	-21%	-$29.8M	0.02%	265
2025 Q1	$130M	Buy	1,428,441 +12,875	+0.9%	+$1.44M	0.03%	257
2024 Q4	$161M	Buy	1,415,566 +394,434	+39%	+$45M	0.03%	242
2024 Q3	$121M	Buy	1,021,132 +278,055	+37%	+$25.6M	0.02%	257
2024 Q2	$59.7M	Buy	+743,077	New	+$67.9M	0.01%	300

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors's BNTX Position: Q1 2026 in Review

Capital International Investors sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 1,134,941 shares — an estimated $108M sold.

Capital International Investors first reported a position in BNTX in Q2 2024 and held it in 7 quarters. The position peaked at $161M in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Capital International Investors reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Capital International Investors sold 1,134,941 BioNTech shares in Q1 2026, an estimated $108M.
Capital International Investors first reported a position in BioNTech in Q2 2024 and held it in 7 quarters.
Capital International Investors's BioNTech position peaked at $161M in Q4 2024.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.